诺华拟最多15亿美元收购Myricx
2026-07-06 07:33:00
据彭博社报道，诺华制药同意收购英国生物科技公司Myricx Bio，交易金额最高达15亿美元。该交易将为诺华增加一款实验性抗癌药物，旨在将更强效治疗直接递送至肿瘤并减少对健康细胞的损伤。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
Former Japan Currency Czar Says Yen Undervalued by Up to 20%Next article：
StandX升级SIP-5A计划
